NO20044138L - Krystallinsk polymorf form av irinotekanhydroklorid - Google Patents

Krystallinsk polymorf form av irinotekanhydroklorid

Info

Publication number
NO20044138L
NO20044138L NO20044138A NO20044138A NO20044138L NO 20044138 L NO20044138 L NO 20044138L NO 20044138 A NO20044138 A NO 20044138A NO 20044138 A NO20044138 A NO 20044138A NO 20044138 L NO20044138 L NO 20044138L
Authority
NO
Norway
Prior art keywords
polymorphic form
irinotecan hydrochloride
crystalline polymorphic
crystalline
irinotecan
Prior art date
Application number
NO20044138A
Other languages
English (en)
Norwegian (no)
Inventor
Natale Barbugian
Attilio Tomasi
Romualdo Forino
Massimo Zampieri
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Publication of NO20044138L publication Critical patent/NO20044138L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
NO20044138A 2002-03-01 2004-09-29 Krystallinsk polymorf form av irinotekanhydroklorid NO20044138L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36068402P 2002-03-01 2002-03-01
PCT/EP2003/001948 WO2003074527A1 (en) 2002-03-01 2003-02-26 Crystalline polymorphic form of irinotecan hydrochloride

Publications (1)

Publication Number Publication Date
NO20044138L true NO20044138L (no) 2004-11-29

Family

ID=27789001

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044138A NO20044138L (no) 2002-03-01 2004-09-29 Krystallinsk polymorf form av irinotekanhydroklorid

Country Status (24)

Country Link
EP (1) EP1487840B1 (ru)
JP (1) JP2005525367A (ru)
KR (1) KR20040091083A (ru)
CN (1) CN1276923C (ru)
AR (1) AR038618A1 (ru)
AT (1) ATE364610T1 (ru)
AU (1) AU2003215594A1 (ru)
BR (1) BR0308133A (ru)
CA (1) CA2477926A1 (ru)
DE (1) DE60314378T2 (ru)
DK (1) DK1487840T3 (ru)
ES (1) ES2287495T3 (ru)
HK (1) HK1075044A1 (ru)
IL (1) IL163820A0 (ru)
MX (1) MXPA04008484A (ru)
NO (1) NO20044138L (ru)
NZ (1) NZ534999A (ru)
PE (1) PE20030923A1 (ru)
PL (1) PL372318A1 (ru)
PT (1) PT1487840E (ru)
RU (1) RU2300535C2 (ru)
TW (1) TWI270374B (ru)
WO (1) WO2003074527A1 (ru)
ZA (1) ZA200406927B (ru)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ541990A (en) * 2003-02-25 2009-04-30 Yakult Honsha Kk Method for preparing polymorphism of irinotecan hydrochloride
ES2245891B1 (es) * 2004-07-09 2006-11-16 Clinmet S.L. "metodo para la obtencion de un excipiente universal para la administracion oral de principios activos farmaceuticos y composiciones de excipientes resultantes del metodo".
CA2590756C (en) * 2004-12-21 2014-09-02 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Stereoselective process and crystalline forms of a camptothecin
US7910737B2 (en) 2005-02-07 2011-03-22 Fermion Oy Process for the manufacturing of 7-ethyl-10-hydroxy camptothecin
ES2430375T3 (es) 2005-02-08 2013-11-20 Fermion Oy Procedimiento para la producción de cloruro de [1,4']bipiperidinil-1'-carbonilo o su clorhidrato
PL1928883T3 (pl) 2005-02-08 2014-03-31 Fermion Oy Sposób otrzymywania chlorowodorku irynotekanu
US7435818B2 (en) * 2005-09-20 2008-10-14 Scinopharm Taiwan, Ltd. Crystal forms of irinotecan hydrochloride
CN101318964B (zh) * 2007-06-07 2010-12-15 上海迪赛诺医药发展有限公司 盐酸伊立替康新晶型及其制备方法
FR2918279B1 (fr) * 2007-07-05 2010-10-22 Aventis Pharma Sa Combinaisons antitumorales contenant un agent inhibiteur de vegf et de l'irinotecan
IT1391757B1 (it) * 2008-11-11 2012-01-27 Antibioticos Spa Irinotecan cloridrato cristallino e metodi per la sua preparazione
CN101659667B (zh) * 2009-09-07 2011-11-02 重庆泰濠制药有限公司 一种盐酸伊立替康的纯化方法
US8546573B2 (en) 2009-11-18 2013-10-01 Cadila Healthcare Limited Process for the preparation of 7-ethyl-10-[4-(1-piperidino)-1-piperdino] carbonyloxy-camptothecin hydrochloride trihydrate
JO3283B1 (ar) 2011-04-26 2018-09-16 Sanofi Sa تركيب يتضمن أفليبيرسيبت, حمض فولينيك, 5- فلورويوراسيل (5- Fu) وإرينوسيتان (FOLFIRI)
CN102866126B (zh) * 2011-07-05 2016-03-23 重庆华邦制药有限公司 一种定量测定化合物中晶型比例的方法
CN102311443B (zh) * 2011-08-24 2014-07-16 上海北卡医药技术有限公司 盐酸伊立替康的新晶型及其制备方法
RU2529831C2 (ru) * 2012-11-30 2014-09-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Российский университет дружбы народов" (РУДН) Способ лечения рака толстой кишки
LT3170005T (lt) 2014-07-18 2019-07-10 Sanofi Paciento, įtariamo, kad serga vėžiu, gydymo afliberceptu rezultato prognozavimo būdas
KR102293907B1 (ko) * 2015-06-30 2021-08-26 한미약품 주식회사 이리노테칸 함유 경구용 고형제제 및 그 제조방법
KR102066402B1 (ko) * 2017-12-22 2020-01-15 대화제약 주식회사 이리노테칸 또는 그의 약제학적으로 허용가능한 염을 포함하는 경구투여용 약제학적 조성물
US10919905B2 (en) * 2019-05-16 2021-02-16 Scinopharm Taiwan, Ltd. Polymorphism for irinotecan free base

Also Published As

Publication number Publication date
CA2477926A1 (en) 2003-09-12
KR20040091083A (ko) 2004-10-27
PE20030923A1 (es) 2003-10-29
ZA200406927B (en) 2006-06-28
TWI270374B (en) 2007-01-11
TW200303753A (en) 2003-09-16
CN1276923C (zh) 2006-09-27
PT1487840E (pt) 2007-09-11
DE60314378T2 (de) 2008-02-28
JP2005525367A (ja) 2005-08-25
AU2003215594A1 (en) 2003-09-16
NZ534999A (en) 2007-03-30
RU2300535C2 (ru) 2007-06-10
EP1487840A1 (en) 2004-12-22
DE60314378D1 (en) 2007-07-26
HK1075044A1 (en) 2005-12-02
WO2003074527A1 (en) 2003-09-12
CN1642958A (zh) 2005-07-20
EP1487840B1 (en) 2007-06-13
RU2004129307A (ru) 2005-04-10
IL163820A0 (en) 2005-12-18
PL372318A1 (en) 2005-07-11
ATE364610T1 (de) 2007-07-15
DK1487840T3 (da) 2007-07-16
BR0308133A (pt) 2005-01-04
MXPA04008484A (es) 2004-12-06
ES2287495T3 (es) 2007-12-16
AR038618A1 (es) 2005-01-19

Similar Documents

Publication Publication Date Title
HK1075044A1 (en) Crystalline polymorphic form of irinotecan hydrochloride
HK1093483A1 (en) Polymorphic form of n-
IL172006A0 (en) Novel crystalline forms of valacyclovir hydrochloride
EP1773339A4 (en) CRYSTALLINE FORM OF DONEPEZIL HYDROCHLORIDE
IL175514A0 (en) Polymorphic form b2 of ziprasidone base
IL176141A0 (en) Crystalline forms of valacyclovir hydrochloride
IL174213A0 (en) A polymorphic form of 3-phenylsulfonyl-8-piperazin-1-yl-quinoline
NO20040266L (no) Nye krystallinske polymorfe former av lerkanidipinhydroklorid og fremgangsmate for fremstilling derav
IL170350A (en) Method for preparing polymorphism of irinotecan hydrochloride
IL192360A0 (en) Crystalline polymorphic forms of olopatadine hydrochloride and processes for their preparation
NO20033408D0 (no) Fremgangsmåte for fremstilling av krystallinske nanopartikler
AU2003245029A1 (en) Novel crystalline forms of donepezil hydrochloride
AU2003245027A1 (en) Novel crystalline forms of ziprasidone hydrochloride
AU2003232719A1 (en) Novel crystalline forms of valacyclovir hydrochloride
IL166592A0 (en) Novel crystalline forms of gatifloxacin
IL165115A0 (en) Novel crystalline forms of gatifloxacin
NO20055097D0 (no) Krystallinske N-formyl-hydroksylaminforbindelser
AU2003289995A1 (en) Anhydrous crystalline form of valacyclovir hydrochloride
ITMI20042437A1 (it) Forma cristallina di rabeprazolo sodico
IL174969A0 (en) Crystalline forms of (+)-and (-) erythro-mefloquine hydrochloride
PT1656358E (pt) Polimorfo est?vel de mesilato de bifeprunox
AU2003250086A1 (en) Crystalline polymorphic and amorphous forms of benazepril hydrochloride
SI1487840T1 (sl) Kristalinična polimorfna oblika irinotekan hidroklorida
IL165690A0 (en) Novel crystalline forms of gatifloxacin
PL1626051T3 (pl) Kryształy solwatu pochodnej kwasu chinolinokarboksylowego

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application